UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Annals of oncology, 2014-06, Vol.25 (6), p.1128-1136

2014

Volltextzugriff (PDF)

Breast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study

Annals of oncology, 2018-10, Vol.29, p.viii109-viii109

2018

Volltextzugriff (PDF)

Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation

Familial cancer, 2019-01, Vol.18 (1), p.1-8

2019

Volltextzugriff (PDF)

PALB2, a major susceptibility gene for breast cancer

Gynécologie, obstétrique, fertilité & sénologie, 2018-11, Vol.46 (10-11), p.701-705

2018

Volltextzugriff (PDF)

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Familial cancer, 2018, Vol.17 (1), p.5-14

2018

Volltextzugriff (PDF)

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer

Pain (Amsterdam), 2017-06, Vol.158 (6), p.1118-1125

2017

Volltextzugriff (PDF)

Breast cancer management: The change is now!

Gynécologie, obstétrique, fertilité & sénologie, 2017-01, Vol.45 (1), p.3-4

2017

Volltextzugriff (PDF)

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Annals of oncology, 2006-01, Vol.17 (1), p.85-92

2006

Volltextzugriff (PDF)

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Genetics in medicine, 2010-12, Vol.12 (12), p.801-807

2010

Volltextzugriff (PDF)

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a french society of paediatric oncology phase II study

Cancer, 2005-12, Vol.104 (12), p.2792-2797

2005

Volltextzugriff (PDF)

French version of FACT-G: validation and comparison with other cancer-specific instruments

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2243-2252

2004

Volltextzugriff (PDF)

Observational study of ferric carboxymaltose (FCM) in france (oncofer study; interim analysis)

Value in health, 2013-05, Vol.16 (3), p.A112-A112

2013

Volltextzugriff (PDF)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Critical reviews in oncology/hematology, 2010-10, Vol.76 (1), p.71-78

2010

Volltextzugriff (PDF)

PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVE

Value in health, 2011, Vol.14 (3), p.A159-A160

2011

Volltextzugriff (PDF)

Biosimilar epoetin for the management of chemotherapy-induced anaemia in elderly patients: a subanalysis of the ORHEO study

Journal of geriatric oncology, 2013-10, Vol.4, p.S82-S82

2013

Volltextzugriff (PDF)

PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES: MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY)

Value in health, 2011, Vol.14 (3), p.A79-A79

2011

Volltextzugriff (PDF)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598

2019

Volltextzugriff (PDF)

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie, obstétrique, fertilité & sénologie, 2022-02, Vol.50 (2), p.121-129

2022

Volltextzugriff (PDF)

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

Annals of oncology, 2001-03, Vol.12 (3), p.397-404

2001

Volltextzugriff (PDF)

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Familial cancer, 2012-06, Vol.11 (2), p.269-278

2012

Volltextzugriff (PDF)

Prevalence and Treatment of Oropharyngeal Candidiasis in Cancer Patients: The CANDIDOSCOPE Study

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S130-S130

2009

Volltextzugriff (PDF)

Abstract P1-10-02: Usage of epoetin alfa biosimilars in the management of chemotherapy-induced anemia in patients with breast cancer: A subanalysis of the ORHEO study

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-10-02

2016

Volltextzugriff (PDF)

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Annals of oncology, 2006-01, Vol.17 (1), p.65-73

2006

Volltextzugriff (PDF)

PALB2, gène majeur de susceptibilité au cancer du sein

Gynécologie Obstétrique Fertilité & Sénologie, 2018-11, Vol.46 (10-11), p.701-705

2018

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Radiothérapie

ThemaSciences Medicales

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(178)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(84)
Female
(73)
Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Middle Aged
(57)
Oncology
(53)
Aged
(51)
Adult
(47)
Male
(36)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Aged, 80 And Over
(28)
Breast Cancer
(25)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Retrospective Studies
(21)
Prognosis
(20)
Tumors
(20)
France
(17)
Radiotherapy Dosage
(17)
Survival Analysis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Breast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study

Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation

PALB2, a major susceptibility gene for breast cancer

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer

Breast cancer management: The change is now!

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a french society of paediatric oncology phase II study

French version of FACT-G: validation and comparison with other cancer-specific instruments

Observational study of ferric carboxymaltose (FCM) in france (oncofer study; interim analysis)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVE

Biosimilar epoetin for the management of chemotherapy-induced anaemia in elderly patients: a subanalysis of the ORHEO study

PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES: MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Prevalence and Treatment of Oropharyngeal Candidiasis in Cancer Patients: The CANDIDOSCOPE Study

Abstract P1-10-02: Usage of epoetin alfa biosimilars in the management of chemotherapy-induced anemia in patients with breast cancer: A subanalysis of the ORHEO study

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

PALB2, gène majeur de susceptibilité au cancer du sein

Aktive Filter

Suchergebnisse filtern